Search results for " plasma membrane"

showing 10 items of 69 documents

Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD

2008

Contains fulltext : 70183.pdf (Publisher’s version ) (Closed access) Previous studies have found heterogeneous association between DAT1-3'-UTR-VNTR and attention deficit hyperactivity disorder (ADHD). Various proportions of conduct disorder (CD) comorbidity in their ADHD samples may partially explain the observational discrepancies. Evidence for this comes from family and twin studies which found ADHD probands with CD (ADHD + CD) are genetically different from those without CD (ADHD - CD). Genotypes of 20 DAT1 markers were analyzed in 576 trios, consisting of 141 ADHD + CD and 435 ADHD - CD. In addition to the classical TDT test, a specific genetic heterogeneity test was performed to identi…

ProbandMaleLinkage disequilibriumGenetics and epigenetic pathways of disease [NCMLS 6]2804 Cellular and Molecular NeuroscienceMedizinComorbidityNeuroinformatics [DCN 3]Linkage Disequilibrium2738 Psychiatry and Mental Health0302 clinical medicineGene FrequencyPerception and Action [DCN 1]Genetics(clinical)ChildGenetics (clinical)GeneticsIncidence10058 Department of Child and Adolescent PsychiatryEuropePsychiatry and Mental healthConduct disorder/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemaleFunctional Neurogenomics [DCN 2]Conduct DisorderGenetic Markers2716 Genetics (clinical)GenotypeSingle-nucleotide polymorphism610 Medicine & healthBiologyMental health [NCEBP 9]Polymorphism Single Nucleotidebehavioral disciplines and activitiesGenomic disorders and inherited multi-system disorders [IGMD 3]03 medical and health sciencesGenetic HeterogeneityCellular and Molecular NeuroscienceCognitive neurosciences [UMCN 3.2]SDG 3 - Good Health and Well-beingmental disordersmedicineAttention deficit hyperactivity disorderHumansddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersAlleleAllelesDopamine Plasma Membrane Transport ProteinsChi-Square DistributionGenetic heterogeneitymedicine.diseaseTwin study030227 psychiatryGenetic defects of metabolism [UMCN 5.1]HaplotypesAttention Deficit Disorder with Hyperactivity030217 neurology & neurosurgery
researchProduct

Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: A reciprocal risk factor for depression and insulin resistance?

2015

International audience; Depression and diabetes are serious diseases with an increasing global prevalence. Intriguingly, recent meta-analyses have highlighted an asymmetrical relationship between the two conditions as depressed patients were found to display a higher risk of developing type 2 diabetes than those individuals suffering from diabetes are to become depressed. Based on recent findings, we favor a hypothesis where by decreased peripheral serotonin (5-HT) transporter (5-HTT) function is a reciprocal risk factor for the comorbidity of depression and diabetes, as it can trigger inflammatory pathogenetic mechanisms of both conditions. Higher intestinal levels of 5-HT and 5-HT3 recept…

Serotoninmedicine.medical_specialty5-HTAntidepressantComorbidityType 2 diabetesBehavioral NeuroscienceInsulin resistanceDiabetes mellitusInternal medicineAnimal models of depressionmedicineAnimalsHumansDepression (differential diagnoses)Serotonin Plasma Membrane Transport ProteinsInflammationIntestinal permeabilitybiologybusiness.industryDepressionInsulin resistancemedicine.diseaseAntidepressive AgentsReceptor InsulinEndotoxemia3. Good healthInsulin receptorEndocrinologyDiabetes Mellitus Type 2Immunologybiology.proteinAntidepressant[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Receptors Serotonin 5-HT3businessSignal Transduction
researchProduct

Effect of family structure and TPH2 G-703T on the stability of dysregulation profile throughout adolescence

2015

Abstract Background Two different polymorphisms (TPH2 G-703T and 5-HTTLPR) involved in the serotonergic pathway have been reported to play a role, both alone and in interaction with the environment, in early and adult emotion regulation. As most of these studies are cross-sectional, we know little about the impact of these polymorphisms over time, particularly during adolescence. Methods Because we were interested in the effects of these polymorphisms and environment (i.e., family structure) at different time-points on the emotional dysregulation profile, we performed a path analysis model in a general adolescent population sample of a five-year follow-up study. Results We found a high stab…

Settore M-PSI/01 - Psicologia GeneraleMaleAdolescentGenotypeEmotional dysregulationTryptophan Hydroxylase5-HTTLPRSerotonergicDevelopmental psychologyDysregulation profileYoung Adult03 medical and health sciences0302 clinical medicinePolymorphism (computer science)TPH2HumansAffective SymptomsAlleleGene–environment interactionYoung adultAllelesTPH2; 5-HTTLPR; Emotional dysregulation; Adolescence; Family structure; Dysregulation profileSerotonin Plasma Membrane Transport ProteinsPolymorphism GeneticTPH2Emotional dysregulationAdolescence030227 psychiatryPsychiatry and Mental healthClinical Psychology5-HTTLPRFemaleGene-Environment InteractionFamily RelationsPsychologyFamily structure030217 neurology & neurosurgeryFollow-Up StudiesClinical psychologyJournal of Affective Disorders
researchProduct

Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter

2001

6-Methoxylated and 8-oxygenated benztropines were prepared and evaluated for their DAT and SERT activity (binding and uptake inhibition). Methoxylation at the two-carbon bridge of benztropine produced a novel class of potent and selective DAT ligands. An interesting enantioselectivity was also observed for this new class of chiral benztropines. The inactivity of the 8-oxygenated analogues seems to point out that, unlike cocaine and its analogues, interactions of benztropine ligands with DAT may be strongly governed by the nitrogen atom.

StereochemistryClinical BiochemistryMolecular ConformationPharmaceutical ScienceNerve Tissue ProteinsMuscarinic AntagonistsLigandsBiochemistryChemical synthesisStructure-Activity RelationshipDopamineBenzatropineDrug DiscoverymedicineMolecular BiologyDopamine transporterBenztropineDopamine Plasma Membrane Transport ProteinsMembrane GlycoproteinsbiologyBicyclic moleculeChemistryOrganic ChemistryMembrane Transport ProteinsBiological activityBenztropinebiology.proteinMolecular MedicineEnantiomerCarrier Proteinsmedicine.drugBioorganic & Medicinal Chemistry Letters
researchProduct

Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopami…

2005

A series of 6alpha- and 6beta-substituted benztropines were synthesized. A marked enantioselectivity was observed for the 6beta-methoxylated benztropines, the (1R)-isomers being more potent than the corresponding (1S) compounds. The racemic 6alpha-methoxy-3-(4',4' '-difluorodiphenylmethoxy)tropane (5 g) was the most potent compound. It has been found that modifications at the 6-position of benztropine might reduce the DAT binding affinity, maintaining otherwise a significant dopamine uptake inhibitory activity. A reinvestigation of the absolute configuration of 6beta-methoxytropinone proved the 6R configuration for the (+)-enantiomer.

StereochemistryDopamineDopamine Plasma Membrane Transport ProteinsMolecular ConformationNerve Tissue ProteinsIn Vitro TechniquesBinding CompetitiveDopamine Plasma Membrane Transport ProteinRadioligand AssayStructure-Activity Relationshipchemistry.chemical_compoundDopamine Uptake InhibitorsCocaineDopaminetriple reuptakeDrug DiscoveryDopamine Uptake InhibitorsmedicineAnimalsStructure–activity relationshipDopamine transporterBenztropineNerve EndingsDopamine Plasma Membrane Transport ProteinsMembrane GlycoproteinsbiologyPutamenMembrane Transport ProteinsStereoisomerismTropaneBiological activityCorpus StriatumBenztropineRatschemistrybiology.proteinMolecular MedicineTropanesmedicine.drug
researchProduct

Synthesis and monoamine uptake inhibition of conformationally constrained 2β-carbomethoxy-3β-phenyl tropanes

2009

A series of 2beta-carbomethoxy-3beta-phenyl tropanes with conformationally constrained nitrogen substituents were synthesized as potential selective dopamine transporter ligands. These novel compounds were examined for their monoamine uptake inhibition potency at the human dopamine transporter (hDAT), the human serotonin transporter (hSERT) and the human noradrenalin transporter (hNET), stably expressed in human embryonic kidney cells (HEK). A SAR-study was conducted to determine the contribution of extended, 4-fluorinated, conformationally constrained C4 chains at the tropane nitrogen to human monoamine transporter affinity and selectivity.

StereochemistryMolecular ConformationLigandsBiochemistryStructure-Activity Relationshipchemistry.chemical_compoundHumansBiogenic MonoaminesPhysical and Theoretical ChemistrySerotonin transporterDopamine transporterSerotonin Plasma Membrane Transport ProteinsDopamine Plasma Membrane Transport ProteinsNorepinephrine Plasma Membrane Transport ProteinsbiologyMonoamine transporterChemistryOrganic ChemistryHEK 293 cellsBiological TransportStereoisomerismTransporterTropaneMonoamine neurotransmitterbiology.proteinSelectivityTropanesOrganic & Biomolecular Chemistry
researchProduct

ADHD and DAT1: Further evidence of paternal over-transmission of risk alleles and haplotype

2010

Contains fulltext : 87259.pdf (Publisher’s version ) (Closed access) We [Hawi et al. (2005); Am J Hum Genet 77:958-965] reported paternal over-transmission of risk alleles in some ADHD-associated genes. This was particularly clear in the case of the DAT1 3'-UTR VNTR. In the current investigation, we analyzed three new sample comprising of 1,248 ADHD nuclear families to examine the allelic over-transmission of DAT1 in ADHD. The IMAGE sample, the largest of the three-replication samples, provides strong support for a parent of origin effect for allele 6 and the 10 repeat allele (intron 8 and 3'-UTR VNTR, respectively) of DAT1. In addition, a similar pattern of over-transmission of paternal ri…

Untranslated region2716 Genetics (clinical)Candidate gene2804 Cellular and Molecular NeuroscienceMedizin610 Medicine & healthMinisatellite RepeatsBiology2738 Psychiatry and Mental HealthGenomic Imprinting03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineSDG 3 - Good Health and Well-beingmental disordersPerception and Action [DCN 1]HumansGenetics(clinical)ddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersRisk factorAllele3' Untranslated RegionsNuclear familyGeneAllelesGenetics (clinical)GeneticsMental Health [NCEBP 9]Dopamine Plasma Membrane Transport ProteinsHaplotypeIntron10058 Department of Child and Adolescent Psychiatry030227 psychiatryPsychiatry and Mental healthHaplotypesAttention Deficit Disorder with Hyperactivity/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being030217 neurology & neurosurgeryAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
researchProduct

Chaperonopathies and chaperonotherapy. Hsp60 as therapeutic target in cancer: potential benefits and risks.

2013

In this minireview we focus on Hsp60 as a target for anticancer therapy. We discuss the new concepts of chaperonopathies and chaperonotherapy and present information on Hsp60 localization in the cell membrane of human tumor cells. We describe novel mechanisms for Hsp60 reaching the extracellular environment that involve membrane-associated stages, as well as data on anti-Hsp60 antibodies found in human sera, both in normal subjects and patients affected by autoimmune diseases. Finally, we discuss possible therapeutic applications of anti-Hsp60 antibodies in cancer treatment, evaluating also side effects on non-tumor cells. In conclusion, the way for investigating Hsp60-targeted anti-tumor t…

animal structuresCellchemical and pharmacologic phenomenaAntineoplastic AgentsBiologycomplex mixturesRisk AssessmentCell membraneDrug Delivery SystemsRisk FactorsNeoplasmsDrug DiscoverymedicineExtracellularAnimalsHumansSecretionPharmacologyMechanism (biology)fungiCancerChaperonin 60medicine.diseasemedicine.anatomical_structureImmunologybiology.proteinCancer researchHsp60 Cpn60 HSPD1 plasma membrane antibodies autoantibodies antitumor immunotherapy anticancer therapy chaperonopathies human sera.HSP60AntibodyCurrent pharmaceutical design
researchProduct

Long-Term Potentiation in the Neonatal Rat Barrel Cortex In Vivo

2012

Long-term potentiation (LTP) is important for the activity-dependent formation of early cortical circuits. In the neonatal rodent barrel cortex, LTP has been studied only in vitro . We combined voltage-sensitive dye imaging with extracellular multielectrode recordings to study whisker stimulation-induced LTP in the whisker-to-barrel cortex pathway of the neonatal rat barrel cortex in vivo . Single whisker stimulation at 2 Hz for 10 min induced an age-dependent expression of LTP in postnatal day (P) 0 to P14 rats, with the strongest expression of LTP at P3–P5. The magnitude of LTP was largest in the activated barrel-related column, smaller in the surrounding septal region, and no LTP could b…

animal structuresPatch-Clamp TechniquesLong-Term PotentiationBiophysicsStimulationBiologyIn Vitro TechniquesStatistics NonparametricIn vivoCortex (anatomy)Evoked Potentials SomatosensoryExtracellularmedicineAnimalsNeuronsSerotonin Plasma Membrane Transport ProteinsCortical circuitsNeonatal ratAfferent PathwaysGeneral Neurosciencemusculoskeletal neural and ocular physiologyAge FactorsLong-term potentiationSomatosensory CortexBarrel cortexElectric StimulationVoltage-Sensitive Dye ImagingRatsmedicine.anatomical_structurenervous systemAnimals NewbornVibrissaeBiophysicsBrief CommunicationsNeuroscience
researchProduct

Transportan 10 Induces Perturbation and Pores Formation in Giant Plasma Membrane Vesicles Derived from Cancer Liver Cells

2023

Continuous progress has been made in the development of new molecules for therapeutic purposes. This is driven by the need to address several challenges such as molecular instability and biocompatibility, difficulties in crossing the plasma membrane, and the development of host resistance. In this context, cell-penetrating peptides (CPPs) constitute a promising tool for the development of new therapies due to their intrinsic ability to deliver therapeutic molecules to cells and tissues. These short peptides have gained increasing attention for applications in drug delivery as well as for their antimicrobial and anticancer activity but the general rules regulating the events involved in cell…

cell-penetrating peptidesdi-4-ANEPPDHQprotein–membrane interactionsgiant plasma membrane vesiclesprotein–membrane interactions; cell-penetrating peptides; Transportan 10; giant plasma membrane vesicles; phasor approach; Nile Red; di-4-ANEPPDHQ; membrane hydrationTransportan 10Nile RedMolecular BiologyBiochemistryphasor approachSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)membrane hydration
researchProduct